ELI LILLY & Co → Sigilon Therapeutics, Inc.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by ELI LILLY & Co

Filed	Form	Issuer	Stake	Shares
2026-07-30	SCHEDULE 13D	Scribe Therapeutics, Inc.	7.30%	1,388,161	view →
2026-07-24	SCHEDULE 13G	Ionetix Corp / DE /	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →